COMMUNIQUÉS West-GlobeNewswire

Peak Physio Launches Subscription Education Platform Arcane Physio for International Clinician Market
18/08/2026
Physiotherapist Laith Cunneen on Channel 7’s Sunrise. Supplied by Arcane Physio Peak Physio has opened Arcane Physio, a clinical education and reference platform, to external subscribers, targeting physiotherapists [...]
Immatics Announces Second Quarter 2026 Financial Results and Business Update
18/08/2026
Enrollment in the SUPRAME Phase 3 trial of anzu-cel (anzutresgene autoleucel, IMA203) remains on track to complete the required randomizations by year-end to support final analysis for the primary PFS endpoint; [...]
CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor
18/08/2026
PRESS RELEASE CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor LONDON – 18 August 2026 -- CHARM Therapeutics (“CHARM”, “The Company [...]
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
18/08/2026
Total revenue increases by 14% to CHF 119 million Operating profit increases by 32% to CHF 32 million and net profit by 77% to CHF 28 million Fosmanogepix phase 3 program on track for data readout and regulatory [...]
Coloplast A/S - Interim Financial Report, 9M 2025/26
18/08/2026
Interim financial results, 9M 2025/26 1 October 2025 - 30 June 2026 Coloplast delivered Q3 organic growth of 6% and 5% EBIT growth 1 in constant currencies. Strong quarter in both Chronic Care ex. China and [...]
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
18/08/2026
Dr. Charuworn’s extensive immunology drug development experience will help accelerate the clinical development of Coultreon’s first-in-class SIK3 inhibitor COL-5671 Leuven, Belgium. August 18, 2026 . Coultreon Biopharma [...]
Cloud 9 Vets calls on the CMA to add at-home pet euthanasia to the new mandatory vet price list
18/08/2026
Research by the UK in-home veterinary provider found 67% of pet owners had no idea a vet could come to the house to put pets to sleep. Chichester, West Sussex, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cloud 9 Vets, a national [...]
Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
18/08/2026
Marking a new approach to innovation in medical robotics, the new centre will bring advances from a leading surgical robotics research group to patients more quickly Smith+Nephew (LSE:SN, NYSE:SNN), the global medical [...]
Transactions in connection with share buy-back program
18/08/2026
Company announcement no. 31 - 26 18 August 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China
18/08/2026
BEIJING, Aug. 18, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for [...]
Functional Brands Announces Second Quarter 2026 Financial Results
17/08/2026
LAKE OSWEGO, Ore., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Functional Brands Inc. (OTC Markets: MEHA), a leading innovator in wellness and performance products, today announced financial results for the second quarter ended [...]
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
17/08/2026
SAN DIEGO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” or the “Company”), a clinical oncology innovator advancing late-stage development of an investigational, [...]
La Fenice Centre Brings Independently Published Frequency Therapy Research to Thornbury
17/08/2026
Co-founder Deanna Pietramala's Brain Science study adds outside validation to the clinic's therapies Thornbury, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Deanna Pietramala, co-founder of La Fenice Centre for Neuro Integrative [...]
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
BRISBANE, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
17/08/2026
Nominating and Governance Chair Carol Burt to become Lead Director. Ron Taylor to retire after more than 21 years of service on Resmed’s Board of Directors. SAN DIEGO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD [...]
Precision Optics to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026
17/08/2026
LITTLETON, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
FOSTER CITY, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
SAN DIEGO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that on August 14, 2026, the Compensation Committee of the Company’s Board of Directors (the “ [...]
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
17/08/2026
– Entitles holders to receive net proceeds from sale of remaining Legacy Biosimilar Assets – – Completes transformation of Coherus Oncology into a fully integrated, innovative immuno-oncology company – REDWOOD CITY, [...]

Pages